NEU 8.52% $14.40 neuren pharmaceuticals limited

Share Price, page-10084

  1. 873 Posts.
    lightbulb Created with Sketch. 72
    Trying to get a handle on the potential value of the upcoming phase 2 NNZ 2591 results...

    If NEU get the $250 mil USD millstone this year ($77 million AUD) and another $65 million in royalty, the cash balance would be about $350 million at the end of the year.

    If the Daybue royalty levels off at $80 million PA leaving a NPAT of say $50 million, and assuming a PE of 16 ($800 million), and the cash, would give a market cap of $1.1 billion....

    Current market cap is $2.4 billion, implying the market is valuing the other trials at $1.3 billion dollars.

    If half of this $1.3 billion is attributed to the upcoming phase 2 results, then could see a $650 million or 25% come off the market cap/share price if results disappoint...

    It will be interesting to see how the market reacts if the results are OK...so neither an obvious failure or success, which I think is most likely.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.40
Change
1.130(8.52%)
Mkt cap ! $1.840B
Open High Low Value Volume
$13.80 $14.45 $13.53 $15.04M 1.062M

Buyers (Bids)

No. Vol. Price($)
1 871 $14.39
 

Sellers (Offers)

Price($) Vol. No.
$14.42 3650 3
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.